Tweet
Ther Clin Risk Manag. 2019 Jul 24;15:911-919. doi: 10.2147/TCRM.S206930. eCollection 2019.
Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study.
Zhang Y1, Zou P2, Gao H2, Yang M1, Yi P1, Gan J3, Shen Y4, Wang W5, Zhang W6, Li J7, Liu P8, Li L1.
Author information
1 The State Key Laboratory for Diagnosis and Treatment of Infectious Disease, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Department of Infectious Disease, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, People's Republic of China. 2 Department of Infectious Disease, Shulan Hospital, Hangzhou, Zhejiang Province, People's Republic of China. 3 Department of Infectious Disease, The First Affiliated Hospital, Medical College of Soochow University, Suzhou, Jiangsu Province, People's Republic of China. 4 Department of Infectious Disease, Shanghai Public Health Clinical Center, Fudan University, Shanghai, People's Republic of China. 5 Department of Infectious Disease, Central Hospital of Huzhou, Zhejiang, People's Republic of China. 6 Department of Infectious Disease, Huashan Hospital, Fudan University, Shanghai, People's Republic of China. 7 Department of Infectious Disease, Jiangsu Province People's Hospital, Jiangsu, People's Republic of China. 8 Department of Infectious Disease, Ningbo No.2 Hospital, Ningbo, Zhejiang Province, People's Republic of China.
Abstract
Background: Avian AIV-H7N9 influenza progresses rapidly and has a high fatality rate. However, it lacks an early effective biomarker to predict disease severity and fatal outcomes successfully. Our study aimed to explore whether the neutrophil-to-lymphocyte ratio (NLR) taken within 24 h after admission can predict disease severity and fatality in AIV-H7N9-infected patients. Methods: We retrospectively studied 237 AIV-H7N9-infected patients from multiple centers from 2013 to 2015. We used univariate analysis and multivariate analysis to compare clinical variables between the survival and fatal groups to evaluate the prognostic value. Results: The NLR taken within 24 h after admission in the fatal group was significantly higher than that in the survival group (P<0.01). Our study found that NLR was independently associated with fatality. The area under the curve (AUC) of the NLR was 0.70, and moreover, when the NLR =19.94, the specificity was 100%, and the sensitivity was 28.4%. The fatality in the NLR ≥19.94 group was significantly increased relative to the patients with an NLR <19.94 (P<0.05). Conclusion: The NLR is potentially a predictive prognostic biomarker in patients infected with the AIV-H7N9 influenza virus.
KEYWORDS:
AIV-H7N9; NLR (neutrophil-to-lymphocyte ratio); biomarker; influenza A
PMID: 31413580 PMCID: PMC6661995 DOI: 10.2147/TCRM.S206930
Free full text
Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study.
Zhang Y1, Zou P2, Gao H2, Yang M1, Yi P1, Gan J3, Shen Y4, Wang W5, Zhang W6, Li J7, Liu P8, Li L1.
Author information
1 The State Key Laboratory for Diagnosis and Treatment of Infectious Disease, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Department of Infectious Disease, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, People's Republic of China. 2 Department of Infectious Disease, Shulan Hospital, Hangzhou, Zhejiang Province, People's Republic of China. 3 Department of Infectious Disease, The First Affiliated Hospital, Medical College of Soochow University, Suzhou, Jiangsu Province, People's Republic of China. 4 Department of Infectious Disease, Shanghai Public Health Clinical Center, Fudan University, Shanghai, People's Republic of China. 5 Department of Infectious Disease, Central Hospital of Huzhou, Zhejiang, People's Republic of China. 6 Department of Infectious Disease, Huashan Hospital, Fudan University, Shanghai, People's Republic of China. 7 Department of Infectious Disease, Jiangsu Province People's Hospital, Jiangsu, People's Republic of China. 8 Department of Infectious Disease, Ningbo No.2 Hospital, Ningbo, Zhejiang Province, People's Republic of China.
Abstract
Background: Avian AIV-H7N9 influenza progresses rapidly and has a high fatality rate. However, it lacks an early effective biomarker to predict disease severity and fatal outcomes successfully. Our study aimed to explore whether the neutrophil-to-lymphocyte ratio (NLR) taken within 24 h after admission can predict disease severity and fatality in AIV-H7N9-infected patients. Methods: We retrospectively studied 237 AIV-H7N9-infected patients from multiple centers from 2013 to 2015. We used univariate analysis and multivariate analysis to compare clinical variables between the survival and fatal groups to evaluate the prognostic value. Results: The NLR taken within 24 h after admission in the fatal group was significantly higher than that in the survival group (P<0.01). Our study found that NLR was independently associated with fatality. The area under the curve (AUC) of the NLR was 0.70, and moreover, when the NLR =19.94, the specificity was 100%, and the sensitivity was 28.4%. The fatality in the NLR ≥19.94 group was significantly increased relative to the patients with an NLR <19.94 (P<0.05). Conclusion: The NLR is potentially a predictive prognostic biomarker in patients infected with the AIV-H7N9 influenza virus.
KEYWORDS:
AIV-H7N9; NLR (neutrophil-to-lymphocyte ratio); biomarker; influenza A
PMID: 31413580 PMCID: PMC6661995 DOI: 10.2147/TCRM.S206930
Free full text